Sir,I read with interest the recent publication on “Adverse drug reactions of nonsteroidal anti-inflammatory drugs (NSAIDS) in orthopedic patients” by Gor and Saksena.[1] The authors have concluded that pharmacovigilance improves recognition of ADRs by the medical students.[1] The authors have not presented any data with medical students in this work, and hence, I was wondering how the conclusion could be set. Nevertheless, I accept that pharmacovigilance is a good tool for monitoring ADRs. Since many NSAIDS are available as over-the-counter drugs, there can be many missed cases of ADRs that are not systematically and spontaneously reported by medical personnel. How to increase the coverage of pharmacovigilance is the next question that we should think.